'Amazon is getting into sports collectibles by investing in fractional marketplace Dibbs, which recently launched a feature allowing users to sell stakes in their items with each other.
The terms of Amazon's investment have not been made public, but Dibbs did raise US$16 million in Series A funding in July.
Among Dibbs' investors are Foundry Group and Tusk Venture Partners and athletes Channing Frye, Chris Paul, Kevin Love, DeAndre Hopkins, Kris Bryant, and Skylar Diggins-Smith.
As large sums are involved, some sports collectibles have become prohibitive to potential buyers and minimize the market for owners who wish to monetize their assets.
Dibbs was founded in 2020 to offer fractional shares of cards and NFTs, making it more affordable to participate while letting collectors unlock value without ceding total ownership.
Dibbs stores and insures any card listed on the platform and charges a 2.9 percent commission per transaction.
If anyone acquires a 100 percent stake in an asset, they can take possession and ship it to their home.


Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Trump Draws Cheers at Ryder Cup as U.S. Trails Europe After Opening Day
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
LA28 Confirms Olympic Athletes Exempt from Trump’s Travel Ban
Instagram Outage Disrupts Thousands of U.S. Users
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election
How did sport become so popular? The ancient history of a modern obsession
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 



